Welcome to our dedicated page for Medigus Ltd. American Depositary Share news (Ticker: MDGS), a resource for investors and traders seeking the latest updates and insights on Medigus Ltd. American Depositary Share stock.
Medigus Ltd. (MDGS) pioneers minimally invasive endoscopic solutions for gastrointestinal disorders, with its flagship SRS system transforming GERD treatment. This dedicated news hub provides investors and medical professionals with timely updates on the company’s technological advancements, regulatory milestones, and strategic partnerships.
Access comprehensive coverage of Medigus’ developments including product launches, clinical trial results, financial performance, and OEM manufacturing initiatives. Our curated repository ensures stakeholders stay informed about innovations in endoscopic stapling systems, ultrasonic alignment technologies, and collaborative healthcare projects.
Key updates feature progress in endoluminal procedures, manufacturing expansions, and intellectual property achievements. Regular updates include earnings reports, executive leadership changes, and research breakthroughs that underscore Medigus’ position in medical device innovation.
Bookmark this page for direct access to official press releases and objective analysis of Medigus’ contributions to minimally invasive surgery. Check regularly for verified updates on the company’s progress in redefining endoscopic intervention standards and expanding global healthcare partnerships.
Medigus Ltd. (Nasdaq:MDGS) announced that its affiliate, Matomy Media Group Ltd., has entered into a merger agreement with Global Automax Ltd., an Israeli automotive importer. This transaction involves a share exchange where Matomy will acquire 100% of Global Automax in exchange for approximately 53% of Matomy’s capital. Global Automax recorded a turnover of NIS 355 million from selling about 3,000 vehicles in 2019. Shareholders of Global Automax may earn additional shares contingent on achieving specified milestones by December 31, 2023.
Medigus Ltd. (Nasdaq:MDGS) announced a non-binding term sheet for a $100,000 investment in Polyrizon Ltd., increasing its stake from 19.9% to approximately 33%. This investment supports Polyrizon's aim to submit products for FDA approval, particularly a Biogel aimed at protecting against COVID-19. Medigus also has the option to invest an additional $50,000 within 60 days of initial closing. The collaboration includes an exclusive license for Medigus to resell Polyrizon's products upon FDA approval.
Medigus Ltd. (NASDAQ:MDGS) has announced the successful soft launch of its AI-driven event platform, Eventer, in the U.S. market. This launch coincided with a virtual book event for The Influencer Code by Amanda Russell, hosted by The Andy Roddick Foundation. The platform allows for automated management, promotion, and billing of events, catering to both individuals and enterprises. Eventer’s client roster includes major companies such as American Express and Live Nation, emphasizing its robust capabilities in online ticketing and event management.
Medigus Ltd. (Nasdaq:MDGS) announced that Purex Inc. will launch COVID-19 related products on Amazon USA, including a portable sanitizer for mobile phones and a UV sterilizer bag. Medigus has acquired a 50.01% interest in Purex as part of its e-commerce strategy. The agreement is expected to close soon, with Purex targeting revenues of approximately $3 million for 2020 and a net profit margin of around 35%. This marks Medigus' entry into the e-commerce sector, leveraging Purex's existing brands and customer base.
Medigus Ltd. (Nasdaq:MDGS) has announced that its affiliate, ScoutCam Inc., received a patent notice of allowance from the U.S. Patent and Trademark Office. This patent covers ScoutCam's design of Printed Circuit Boards (PCBs) that enables the creation of smaller cameras. These advancements facilitated ScoutCam's selection for NASA's third Robotic Refueling Mission (RRM3) held in October 2020. The new technology also presents valuable opportunities in the medical field, particularly for disposable endoscopes, which are crucial in the U.S. medical market, conducting approximately 75 million procedures annually.
Medigus Ltd. (Nasdaq:MDGS) announced that its subsidiary, ScoutCam Inc., has been certified as a vendor by the Israeli Ministry of Defense. This certification allows ScoutCam to participate in tenders and provide its innovative visual solutions directly to defense agencies in Israel, expanding its market reach. The company has also gained recognition from NASA and a Fortune 500 healthcare corporation. ScoutCam specializes in miniature cameras designed for defense and aerospace applications, offering advanced technology for various operational conditions.
Medigus Ltd. (Nasdaq:MDGS) announced the successful use of its micro ScoutCam 8.0 HD during NASA's Robotic Refueling Mission 3 (RRM3), held from October 19th-22nd, 2020. This micro camera, developed for NASA, performed as the borescope camera for the Visual Inspection Poseable Invertebrate Robot 2 (VIPIR2). The mission showcases Medigus' commitment to advanced technology, having previously used the micro ScoutCam 1.2 during earlier phases. CEO Yaron Silberman expressed pride in the collaboration, highlighting the competitive bidding process with U.S. Government.
Medigus Ltd. (Nasdaq:MDGS) has announced that Smart Repair Pro, a data-driven e-commerce company, has completed all regulatory processes required by Amazon, enabling its store launch in Australia. This marks Smart Repair Pro's entry into the Australian market, following approvals to launch in five European countries and current operations in the U.S. Medigus is acquiring a controlling interest in Smart Repair Pro and Purex, owning 50.01% of both. The companies aim for 2020 revenues of approximately $3 million, with a net profit margin of around 35%.
Medigus Ltd. (Nasdaq:MDGS) announced a strategic investment in Eventer Technologies Ltd., acquiring a 50.1% stake with an investment of up to $1 million and a loan of $1.25 million. Eventer, a platform for automated ticketing and event management, has hosted 22,700 events, reflecting a 118% annual growth. The company aims to expand its reach, particularly in North America, capitalizing on increased demand for online events. With a commission structure of 3%-6% on ticket sales, Eventer generated approximately NIS 88 million in ticket sales in 2019.
Medigus Ltd. (NASDAQ:MDGS) has increased its stake in Gix Internet Ltd. to approximately 33%, becoming its largest shareholder. Gix Internet reported revenues of $18.5 million for Q2 2020, with a market cap of $10 million as of October 14, 2020. This move allows Medigus to convert Linkury Shares into Ordinary Shares of Gix Internet, totaling around 9.86 million shares, pending shareholder approval. The company's technology is integrated with major platforms including Google and Apple.
